Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
Top Cited Papers
- 1 April 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 359 (9316) , 1453-1460
- https://doi.org/10.1016/s0140-6736(02)08430-1
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Hepatitis C Virus InfectionNew England Journal of Medicine, 2001
- Pharmacodynamic Comparison of Single Doses of IFN-beta 1a and IFN-beta 1b in Healthy VolunteersJournal of Interferon & Cytokine Research, 1999
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosisBrain, 1995
- Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosisAnnals of Neurology, 1992
- Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patientsAnnals of Neurology, 1989
- An Assessment of Clinically Useful Measures of the Consequences of TreatmentNew England Journal of Medicine, 1988
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSISAnnals of the New York Academy of Sciences, 1965